SPI1 and agammaglobulinemia: The first report identified six unrelated individuals with agammaglobulinemia harboring SPI1 variants that destabilized the PU.1 protein, impaired its nuclear localization, and reduced chromatin accessibility, resulting in developmental arrest of B cells and loss of dendritic cells (1).